Olfr633, an olfactory receptor protein, plays a crucial role in the initiation of the neuronal response responsible for the perception of smell. Belonging to the large family of G-protein-coupled receptors (GPCRs), Olfr633 exhibits a unique structure with a 7-transmembrane domain, akin to neurotransmitter and hormone receptors. The gene family associated with olfactory receptors constitutes the largest in the genome, and the nomenclature assigned to these genes is organism-specific, independent of other organisms. The primary function of Olfr633 is to recognize odorant molecules, leading to G protein-mediated transduction of odorant signals within the olfactory system. The transduction process initiated by Olfr633 involves intricate cellular and molecular events. Upon interaction with specific odorant molecules in the nose, Olfr633 activates downstream signaling pathways, ultimately resulting in the neuronal response that characterizes the perception of a smell. The receptor's involvement in the GPCR family highlights its significance in cellular communication and signal transduction. Notably, Olfr633 shares structural features with receptors that participate in neurotransmission and hormonal responses, underlining the evolutionary conservation of its role in sensory perception.
In terms of inhibition, targeting Olfr633 involves a nuanced understanding of the signaling pathways associated with its function. Chemical inhibitors influence Olfr633 expression and function either directly or indirectly by modulating specific cellular pathways. For instance, certain inhibitors act on the cAMP/PKA pathway, affecting downstream factors that negatively regulate Olfr633 expression. Others target key kinases like Akt, disrupting the PI3K/Akt pathway known to cross-talk with olfactory receptor signaling. Additionally, inhibitors may impact tyrosine kinases or TGF-β receptors, indirectly influencing Olfr633 expression through the modulation of associated pathways. Indirect inhibition of Olfr633 often involves targeting broader cellular processes such as the MAPK and mTOR pathways, affecting downstream events crucial for GPCR function and odorant signal transduction. These inhibitors alter the cellular environment, impacting the neuronal response associated with olfactory perception. The intricate web of interconnected signaling pathways emphasizes the complexity of Olfr633 regulation and inhibition. Understanding the specific biochemical and cellular mechanisms influenced by these inhibitors provides insights into potential avenues for modulating Olfr633 expression and function, opening new avenues for research in the field of sensory perception. Overall, elucidating the multifaceted interplay between Olfr633 and its inhibitors contributes to a deeper understanding of olfactory receptor function and regulation at the molecular level.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Budesonide | 51333-22-3 | sc-202980 sc-202980A sc-202980B sc-202980C | 50 mg 100 mg 200 mg 500 mg | $77.00 $88.00 $151.00 $343.00 | 3 | |
Glucocorticoid receptor agonist. Budesonide modulates the cAMP/PKA pathway, influencing downstream factors that negatively regulate Olfr633 expression. This indirect inhibition occurs through altered cellular signaling, impacting olfactory receptor function. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $178.00 $325.00 | 67 | |
MK-2206 dihydrochloride disrupts the PI3K/Akt pathway, known to cross-talk with olfactory receptor signaling. By inhibiting Akt, it indirectly influences Olfr633 expression and transduction of odorant signals, providing a potential avenue for modulation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3-kinase inhibitor. Wortmannin disrupts the PI3K/Akt pathway, influencing olfactory receptor signal transduction. Its indirect inhibition of Olfr633 occurs through the alteration of downstream signaling events, affecting the neuronal response and perception of smell. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
TGF-β receptor inhibitor. SB-431542 targets TGF-β receptors, impacting TGF-β signaling pathways. This indirectly influences Olfr633 expression through the modulation of pathways associated with GPCR transduction of odorant signals, providing a potential inhibitory mechanism. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
MEK inhibitor. U0126 disrupts the MAPK pathway, influencing olfactory receptor signaling. Its indirect inhibition of Olfr633 occurs through altered cellular signaling, impacting downstream events associated with GPCR function and odorant signal transduction. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3-kinase inhibitor. LY294002 disrupts the PI3K/Akt pathway, affecting olfactory receptor signal transduction. This indirect inhibition of Olfr633 occurs through the modulation of downstream events associated with GPCR function, influencing the perception of smell. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Src family kinase inhibitor. Dasatinib targets Src kinases, affecting cellular signaling pathways. This indirectly impacts Olfr633 expression through the modulation of pathways associated with GPCR function and odorant signal transduction, providing a potential inhibitory effect. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor. PD98059 disrupts the MAPK pathway, influencing olfactory receptor signaling. Its indirect inhibition of Olfr633 occurs through altered cellular signaling, impacting downstream events associated with GPCR function and odorant signal transduction. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor. Rapamycin disrupts the mTOR pathway, influencing cellular processes. This indirect inhibition of Olfr633 occurs through the modulation of pathways associated with GPCR function and odorant signal transduction, providing a potential inhibitory mechanism. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor. SP600125 disrupts the JNK pathway, influencing olfactory receptor signaling. Its indirect inhibition of Olfr633 occurs through altered cellular signaling, impacting downstream events associated with GPCR function and odorant signal transduction. | ||||||